KnowMe

Company Overview

Snapshot

Founded in February 2019 by Anat Burstein, KnowMe operates with 1–10 employees. The company is currently in the Pre-Funding stage and holds a patent for its technology. KnowMe is developing an AI-powered mobile diagnostic tool for early autism detection.

Business overview

KnowMe is developing an AI mobile-based, patented tool that utilizes deep learning algorithms to track child development. By processing vast amounts of information gathered via biosensors on a smart device in real-time, the company aims to provide precise, affordable, and accessible diagnosis of Autism Spectrum Disorder in a home environment. This individualized diagnostic tool is designed for ease of use, requiring no prior knowledge or training, and can be used repeatedly. KnowMe operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Medical Diagnostics and Medical Devices, serving patients and healthcare providers in markets such as North America, Europe, Asia, and Australia.

Company Intelligence Q&A

What is KnowMe's primary focus?

KnowMe is focused on developing an AI diagnostic tool for the early diagnosis of Autism Spectrum Disorder, utilizing deep learning algorithms and mobile-based biosensors.

When was KnowMe founded and by whom?

KnowMe was founded in February 2019 by Anat Burstein.

What is the current status of KnowMe?

KnowMe is currently non-active, having ceased operations in December 2024.

What is the product stage of KnowMe's technology?

KnowMe's product, KnowMe Care, is currently in the Clinical Trial stage, indicating it is undergoing testing to evaluate its safety and efficacy before potential market release.

In which geographic markets does KnowMe operate or target?

KnowMe targets geographic markets including North America, Europe, Asia, and Australia.